2023 Greenhouse Gas (GHG) Emissions Verification Report

2023 Greenhouse Gas (GHG) Emissions Report

Newland Pharmaceutical Co., Ltd. is located on the east side of the south section of Weiwu Avenue, Changge Industrial Cluster Area, Xuchang City, Henan Province. Founded in September 2005, the company is mainly engaged in the R&D, production and sales of pharmaceutical intermediates, APIs and chemical pharmaceutical preparations. The company covers a total area of approximately 100,000 m², wit

In accordance with the Measures for Public Participation in Environmental Impact Assessment and other relevant regulations, we hereby publish the "Annual 3,000-Ton API Side Chain Renovation Project of Newland Pharmaceutical Co., Ltd. (Draft for Public Comment)" and solicit public opinions.

Henan Newland Pharmaceutical Co., Ltd. was established in September 2005 with a registered capital of RMB 133.36 million. It is mainly engaged in the R&D, production and sales of pharmaceutical intermediates and APIs, and is a globally important producer of L-p-hydroxyphenylglycine, a synthetic side chain of amoxicillin. The company has led or participated in the formulation of industry standa